We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Research Partnership to Advance Genomics and Bioinformatics Technology

By LabMedica International staff writers
Posted on 06 Feb 2012
Print article
A new collaboration using high-performance pipeline automation technology has been initiated to accelerate next-generation sequencing and bioinformatics capabilities. Moreover, the collaborative program supports the advancement of bioinformatics, genetic pipelines, and applied high-performance computing.

Appistry, Inc. (St. Louis, MO, USA), a company focused on solving complex, data intensive problems, announced a strategic partnership with the University of Missouri (UM; Columbia, USA) to enhance the school’s genomic research. Through the partnership, the University of Missouri will deploy Ayrris/BIO, Appistry’s high-performance pipeline automation system.

Through the UM Bioinformatics Consortium, a resource for high-performance computational infrastructure geared toward facilitating intercampus communication and bioinformatics research collaborations, the University of Missouri has emerged as the Midwest’s leading innovator in genomic research and data analysis. While the university’s agricultural genomics research continues to create perceptive returns, with computational data storage nearing capacity, the deployment of a data life cycle management system emerged as a requirement. Appistry’s computational storage technology will remove data logjams and manage workloads while enabling downstream bioinformatics at scale.

As part of the partnership, Appistry’s technologies will enable the University of Missouri to construct, manage, and execute high throughput computing techniques to develop new pipelines for accurate, cost-effective, and high quality analysis of genomic data. The University of Missouri will deploy the Ayrris/BIO high-performance computing platform to increase the computational range of their automated sequencing pipelines and alleviate their data management burden. The early research projects using the appliance will be focused on plant and animal genomics work that is ongoing at the MU campus.

“We are really excited about the opportunities that this partnership with Appistry brings to the University,” commented Gordon Springer, PhD, department of computer science scientific director, at University of Missouri Bioinformatics Consortium. “Our ability to quickly and efficiently carry out the early and secondary analysis of sequence data to answer important questions about plant, animal, and human genomics problems with new state of the art technologies is like the opening of a new bridge on the path to discovery. Where we end up is unknown, but that’s what makes it so exciting; to be able to discover new things about ourselves and nature.”

“The opportunity to partner with our state’s most influential research and academic organization is not only thrilling--it’s a critical development for the advancement of bioinformatics and next-generation sequencing,” said Kevin Haar, CEO of Appistry. “Regional collaborations like this are necessary to accelerate innovation in life sciences and to complete the life cycle of genomic research and analysis in order to support the advancement of personalized medicine and other medical breakthroughs.”

Related Links:
Appistry
University of Missouri


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.